BIG
ANAB icon

Brookwood Investment Group’s AnaptysBio ANAB Stock Holding History

Brookwood Investment Group’s Portfolio ANAB Stock Details ANAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$741K Buy
+13,362
New +$719K 0.09% 208

Other funds holding ANAB

EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AAA
Affinity Asset Advisors New York $1.94B AUM 374.45% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Brookwood Investment Group's ANAB Position: Q1 2026 in Review

Brookwood Investment Group opened a new position in AnaptysBio (ANAB) in Q1 2026: 13,362 shares worth $741K. The stake represents 0.09% of the portfolio and ranks #208 among its holdings.

207 funds tracked by Wall St. Rank hold ANAB as of Q1 2026.

  • Brookwood Investment Group held 13,362 shares of AnaptysBio worth $741K as of Q1 2026.
  • AnaptysBio was a new Brookwood Investment Group position in Q1 2026.
  • AnaptysBio made up 0.09% of Brookwood Investment Group's portfolio in Q1 2026, its #208 holding.
  • 207 funds tracked by Wall St. Rank held AnaptysBio as of Q1 2026.

Based on Brookwood Investment Group's 13F filing for Q1 2026, filed 4 May 2026.